AGNG
Global X Aging Population ETF [AGNG] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
AGNG Stock Summary
Top AGNG Correlated Resources
AGNG
Top 10 Correlated ETFs
AGNG
Top 10 Correlated Stocks
AGNG
In the News
AGNG Financial details
Company Rating
-
Market Cap
58.09M
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
0.14
Dividend %
0.95%
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-4.72%
SMA50
-0.52%
SMA100
6.05%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
24.41-30.59
52W High
+17.87%
52W Low
+47.33%
RSI
31.27
Rel Volume
3
Avg Volume
6.28K
Volume
18.87K
Perf Week
-3.73%
Perf Month
-4.02%
Perf Quarter
6.83%
Perf Half Y
5.77%
-
-
-
-
Beta
0.78
-
-
Volatility
0.42%, 0.93%
Prev Close
-1.94%
Price
35.36
Change
-2.51%
AGNG Financial Performance
AGNG Frequently Asked Questions
What is Global X Aging Population ETF stock symbol ?
Global X Aging Population ETF is a US stock and trading under the symbol AGNG
What is Global X Aging Population ETF stock quote today ?
Global X Aging Population ETF stock price is $35.36 today.
Is Global X Aging Population ETF stock public?
Yes, Global X Aging Population ETF is a publicly traded company.
Company Profile
- Volume Average 6.28K
- Market Capitalization 58.09M
- Headquarters New York,US
- IPO Date 2016-05-10
-
Website
http://www.globalxfunds.com/funds/lngr/ 
The fund invests more than 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies in developed markets that facilitate the demographic trend of longer average life spans and the aging of the global population, including but not limited to companies involved in biotechnology, medical devices, pharmaceuticals, senior living facilities and specialized health care services.
